Pediatric Metabolic Syndrome Predicts Adulthood Metabolic Syndrome, Subclinical Atherosclerosis, and Type 2 Diabetes Mellitus but Is No Better Than Body Mass Index Alone

Costan G. Magnussen; Juha Koskinen; Wei Chen; Russell Thomson; Michael D. Schmidt; Sathanur R. Srinivasan; Mika Kivimäki; Noora Mattsson; Mika Kähönen; Tomi Laitinen; Leena Taittonen; Tapani Rönnemaa; Jorma S.A. Viikari; Gerald S. Berenson; Markus Juonala; Olli T. Raitakari

Journal ArticleOPEN ACCESS

Pediatric Metabolic Syndrome Predicts Adulthood Metabolic Syndrome, Subclinical Atherosclerosis, and Type 2 Diabetes Mellitus but Is No Better Than Body Mass Index Alone

Magnussen C
Koskinen J
Chen W
et al.

Circulation (2010) 122(16) 1604-1611

DOI: 10.1161/circulationaha.110.940809

N/ACitations

37Readers

Abstract

Background—The clinical utility of identifying pediatric metabolic syndrome (MetS) is controversial. This study sought to determine the status of pediatric MetS as a risk factor for adult subclinic...

Cite

CITATION STYLE

APA

Magnussen, C. G., Koskinen, J., Chen, W., Thomson, R., Schmidt, M. D., Srinivasan, S. R., … Raitakari, O. T. (2010). Pediatric Metabolic Syndrome Predicts Adulthood Metabolic Syndrome, Subclinical Atherosclerosis, and Type 2 Diabetes Mellitus but Is No Better Than Body Mass Index Alone. Circulation, 122(16), 1604–1611. https://doi.org/10.1161/circulationaha.110.940809

Pediatric Metabolic Syndrome Predicts Adulthood Metabolic Syndrome, Subclinical Atherosclerosis, and Type 2 Diabetes Mellitus but Is No Better Than Body Mass Index Alone

Abstract

Cite

Register to see more suggestions